Sinopharm Group Co. Ltd. will hold an extraordinary general meeting on December 19, 2025, at its Sinopharm Group Building in Shanghai, China. During the meeting, shareholders will consider and vote on the appointment of Mr. Jin Bin as a non-executive Director of the sixth session of the Board, with authorization for the Board to determine his remuneration and for the Chairman or any executive Director to enter into a service contract or related agreements with him. Additionally, the appointment of Ms. Li Ying as a non-executive Director of the sixth session of the Board will be considered, along with similar authorization for the Board regarding her remuneration and service contract arrangements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251204-11942996), on December 03, 2025, and is solely responsible for the information contained therein.
Comments